Biofrontera Inc. (BFRI): Price and Financial Metrics

Biofrontera Inc. (BFRI): $0.64

0.02 (+3.14%)

POWR Rating

Component Grades














  • BFRI scores best on the Sentiment dimension, with a Sentiment rank ahead of 97.97% of US stocks.
  • The strongest trend for BFRI is in Growth, which has been heading up over the past 78 days.
  • BFRI ranks lowest in Stability; there it ranks in the 16th percentile.

BFRI Stock Summary

  • BIOFRONTERA INC's market capitalization of $17,354,351 is ahead of just 7.5% of US-listed equities.
  • BIOFRONTERA INC's stock had its IPO on October 29, 2021, making it an older stock than only 1.41% of US equities in our set.
  • BIOFRONTERA INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -80.79%, greater than the shareholder yield of only 7.32% of stocks in our set.
  • Stocks that are quantitatively similar to BFRI, based on their financial statements, market capitalization, and price volatility, are HURC, LGL, NVFY, ROCK, and AIR.
  • To check out BIOFRONTERA INC's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001858685.

BFRI Valuation Summary

  • BFRI's EV/EBIT ratio is -3.6; this is 154.96% lower than that of the median Healthcare stock.
  • BFRI's price/sales ratio has moved down 1.6 over the prior 17 months.

Below are key valuation metrics over time for BFRI.

Stock Date P/S P/B P/E EV/EBIT
BFRI 2023-03-17 0.6 0.7 -27.2 -3.6
BFRI 2023-03-16 0.6 0.7 -26.3 -2.2
BFRI 2023-03-15 0.6 0.7 -26.1 -1.9
BFRI 2023-03-14 0.6 0.7 -26.1 -1.9
BFRI 2023-03-13 0.5 0.6 -23.9 1.5
BFRI 2023-03-10 0.5 0.7 -1.2 1.1

BFRI Stock Price Chart Interactive Chart >

Price chart for BFRI

BFRI Price/Volume Stats

Current price $0.64 52-week high $6.12
Prev. close $0.62 52-week low $0.55
Day low $0.64 Volume 4,265
Day high $0.64 Avg. volume 121,707
50-day MA $0.79 Dividend yield N/A
200-day MA $1.17 Market Cap 17.09M

Biofrontera Inc. (BFRI) Company Bio

Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.

BFRI Latest News Stream

Event/Time News Detail
Loading, please wait...

BFRI Latest Social Stream

Loading social stream, please wait...

View Full BFRI Social Stream

Latest BFRI News From Around the Web

Below are the latest news stories about BIOFRONTERA INC that investors may wish to consider to help them evaluate BFRI as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning!

William White on InvestorPlace | March 17, 2023

Biofrontera Inc. to Attend 2023 American Academy of Dermatology Annual Meeting

Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will be hosting a booth showcasing its innovative, FDA-approved products at the 2023 American Academy of Dermatology (AAD) Annual Meeting taking place March 17-21, 2023 in New Orleans, LA.

Yahoo | March 17, 2023

Biofrontera Inc. (NASDAQ:BFRI) Analysts Just Slashed Next Year's Estimates

The latest analyst coverage could presage a bad day for Biofrontera Inc. ( NASDAQ:BFRI ), with the analysts making...

Yahoo | March 11, 2023

Biofrontera Inc. (NASDAQ:BFRI) Q4 2022 Earnings Call Transcript

Biofrontera Inc. (NASDAQ:BFRI) Q4 2022 Earnings Call Transcript March 8, 2023 Operator: Greetings and welcome to the Biofrontera, Inc. Fourth quarter 2022 Financial Results Call. At this time, all participants are in a listen-only mode and a question-and-answer session will follow the form of presentation. I will now turn the conference over to your host, […]

Yahoo | March 10, 2023

CORRECTING AND REPLACING: Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results

Biofrontera, Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced financial results for the three and twelve months ended December 31, 2022.

Yahoo | March 9, 2023

Read More 'BFRI' Stories Here

BFRI Price Returns

1-mo N/A
3-mo -31.91%
6-mo -30.66%
1-year -78.81%
3-year N/A
5-year N/A
YTD -30.18%
2022 -87.81%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7246 seconds.